Work

Clinical Outcomes Following Bridging Radiotherapy in Relapsed/Refractory Multiple Myeloma Patients prior to Chimeric Antigen Receptor T-Cell Therapy

Year: 2025

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2025.06.3238

Authors: P.E. Perez, J.Y. Nakashima, J. Peterson, A. Ruane, G. De Avila, F.L. Locke, H.D. Liu, T. Nishihori, O.C. Puglianini, M. Alsina, A. Garjales-Cruz, R. Baz, L. Gardner, B.D. Shah, K. Shain, M.D. Jain, D. Hansen, C. Freeman, N.B. Figura

Institutions: University of South Florida, Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4414574131

FWCI: 0.734

Cites:

Cited by: 1

Related to: 10